Analyst Price Targets — CC
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| August 13, 2026 11:41 am | — | BMO Capital | $18.00 | $15.24 | TheFly | Chemours price target lowered to $18 from $26 at BMO Capital |
| August 13, 2026 11:30 am | Duffy Fischer | Goldman Sachs | $17.00 | $15.24 | TheFly | Chemours price target lowered to $17 from $19 at Goldman Sachs |
| August 10, 2026 10:58 am | Vincent Andrews | Morgan Stanley | $18.00 | $15.75 | TheFly | Chemours price target lowered to $18 from $21 at Morgan Stanley |
| August 10, 2026 7:01 am | Joshua Spector | UBS | $18.00 | $15.75 | StreetInsider | UBS Downgrades Chemours (CC) to Neutral |
| August 6, 2026 11:11 am | — | RBC Capital | $22.00 | $14.59 | TheFly | Chemours price target lowered to $22 from $26 at RBC Capital |
| August 5, 2026 11:29 am | — | Mizuho Securities | $22.00 | $17.93 | TheFly | Chemours price target lowered to $22 from $25 at Mizuho |
| May 13, 2026 11:03 am | — | Alembic Global | $30.00 | $24.67 | TheFly | Chemours price target raised to $30 from $24 at Alembic Global |
| May 11, 2026 12:16 pm | Vincent Andrews | Morgan Stanley | $21.00 | $24.45 | TheFly | Chemours price target raised to $21 from $17 at Morgan Stanley |
| May 11, 2026 11:33 am | — | RBC Capital | $29.00 | $23.04 | TheFly | Chemours price target raised to $29 from $26 at RBC Capital |
| May 8, 2026 2:43 pm | — | UBS | $30.00 | $22.86 | TheFly | Chemours price target raised to $30 from $29 at UBS |
Latest News for CC
NEW YORK, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of The Chemours Company (“Chemours” or the “Company”) (NYSE: CC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
NEW YORK, Aug. 27, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of The Chemours Company ("Chemours" or the "Company") (NYSE: CC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
RALEIGH, N.C., Aug. 27, 2026 (GLOBE NEWSWIRE) -- This week, the Honorable James C.
NEW YORK, Aug. 25, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of The Chemours Company (“Chemours” or the “Company”) (NYSE: CC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
WILMINGTON, Del., Aug. 25, 2026 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions (TSS), Titanium Technologies (TT), and Advanced Performance Materials (APM), today announced the release of its 2025 Sustainability Report.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.